HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BET 3: emergency management of anthracycline extravasation.

Abstract
A short cut review was carried out to establish whether intravenous dexrazoxane reduces the risk of tissue necrosis after extravasation of the chemotherapy agent anthracycline. One paper directly addressed the question. The clinical bottom line is that intravenous dexrazoxane appears to be safe and may reduce the risk of tissue necrosis after extravasation of anthracycline.
AuthorsDavid Drake
JournalEmergency medicine journal : EMJ (Emerg Med J) Vol. 29 Issue 9 Pg. 777-9 (Sep 2012) ISSN: 1472-0213 [Electronic] England
PMID22903427 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antibiotics, Antineoplastic
  • Chelating Agents
  • Razoxane
  • Doxorubicin
Topics
  • Adult
  • Antibiotics, Antineoplastic (adverse effects)
  • Chelating Agents (therapeutic use)
  • Doxorubicin (adverse effects)
  • Emergency Service, Hospital
  • Extravasation of Diagnostic and Therapeutic Materials (etiology, pathology, therapy)
  • Hodgkin Disease (drug therapy, pathology)
  • Humans
  • Male
  • Razoxane (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: